BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33969101)

  • 1. Sarcoidosis mimicking metastases in an echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase positive non-small-lung cancer patient: A case report.
    Chen X; Wang J; Han WL; Zhao K; Chen Z; Zhou JY; Shen YH
    World J Clin Cases; 2021 May; 9(13):3140-3146. PubMed ID: 33969101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare coexistence of sarcoidosis and lung adenocarcinoma.
    Kachalia AG; Ochieng P; Kachalia K; Rahman H
    Respir Med Case Rep; 2014; 12():4-6. PubMed ID: 26029525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ground-glass nodule in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK)-positive lung cancer: a case report.
    Owada Y; Yonechi A; Higuchi M; Suzuki H
    World J Surg Oncol; 2016 Mar; 14():81. PubMed ID: 26964537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK inhibitors in the treatment of advanced NSCLC.
    Gridelli C; Peters S; Sgambato A; Casaluce F; Adjei AA; Ciardiello F
    Cancer Treat Rev; 2014 Mar; 40(2):300-6. PubMed ID: 23931927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of exceptional clinical response to chemoradiotherapy and tyrosine kinase inhibitors in a patient with EML4-ALK fusion variant 1 non-small cell lung cancer.
    Xu X; Liu D; Wen J; Chen J; Fan M
    Transl Lung Cancer Res; 2020 Dec; 9(6):2500-2507. PubMed ID: 33489810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
    Dubey AP; Pathi N; Viswanath S; Rathore A; Pathak A; Sud R
    Indian J Cancer; 2017; 54(1):203-208. PubMed ID: 29199691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of
    Xia G; Huang J; Ni J; Song M; Zhang J; Hofman P; Christopoulos P; Grenda A; Huang M
    Transl Lung Cancer Res; 2023 Mar; 12(3):637-646. PubMed ID: 37057117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib.
    Chen HF; Wang WX; Xu CW; Huang LC; Li XF; Lan G; Zhai ZQ; Zhu YC; Du KQ; Lei L; Fang MY
    Lung Cancer; 2020 Apr; 142():59-62. PubMed ID: 32114282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report.
    Fan J; Wu J; Huang B; Zhu Y; Shi H; Dai X; Nie X
    Diagn Pathol; 2020 May; 15(1):42. PubMed ID: 32375829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples.
    Abe H; Kawahara A; Azuma K; Taira T; Takase Y; Fukumitsu C; Murata K; Yamaguchi T; Akiba J; Ishii H; Okamoto I; Hoshino T; Takamori S; Kage M
    J Thorac Oncol; 2015 May; 10(5):800-805. PubMed ID: 25898958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.
    Sakairi Y; Nakajima T; Yasufuku K; Ikebe D; Kageyama H; Soda M; Takeuchi K; Itami M; Iizasa T; Yoshino I; Mano H; Kimura H
    Clin Cancer Res; 2010 Oct; 16(20):4938-45. PubMed ID: 20926401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report.
    Zhang L; Li Y; Zhang S; Gao C; Nie K; Ji Y
    Cancer Biol Med; 2018 May; 15(2):178-181. PubMed ID: 29951342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinicopathological features of the echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase fusion gene in Chinese patients with advanced non-small-cell lung cancer.
    Liu YT; Shi YK; Hao XZ; Wang L; Li JL; Han XH; Li D; Zhou YJ; Tang L
    Thorac Cancer; 2014 May; 5(3):255-60. PubMed ID: 26767009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report.
    Watanabe H; Tamura T; Shiozawa T; Ohara G; Kagohashi K; Kawaguchi M; Kurishima K; Satoh H; Hizawa N
    Mol Clin Oncol; 2015 Jul; 3(4):889-891. PubMed ID: 26171201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of lung adenocarcinoma after an interval of 15 years revealed by demonstration of the same type of EML4-ALK fusion gene.
    Tsukamoto Y; Kanamori K; Watanabe T; Mikami K; Ieki R; Nakano T; Kajimoto K; Hirota S
    Pathol Res Pract; 2014 Dec; 210(12):1112-6. PubMed ID: 25238939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
    Kimura H; Nakajima T; Takeuchi K; Soda M; Mano H; Iizasa T; Matsui Y; Yoshino M; Shingyoji M; Itakura M; Itami M; Ikebe D; Yokoi S; Kageyama H; Ohira M; Nakagawara A
    Lung Cancer; 2012 Jan; 75(1):66-72. PubMed ID: 21757253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer.
    Pyo KH; Lim SM; Kim HR; Sung YH; Yun MR; Kim SM; Kim H; Kang HN; Lee JM; Kim SG; Park CW; Chang H; Shim HS; Lee HW; Cho BC
    J Thorac Oncol; 2017 Mar; 12(3):491-500. PubMed ID: 27836576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib.
    Shi R; Varella-Garcia M; Li M; Ludkovski O; Danesh A; Ng C; Pham NA; Pugh T; Shepherd FA; Tsao MS
    J Thorac Oncol; 2016 Dec; 11(12):2248-2252. PubMed ID: 27613526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of sarcoidosis accompanied by lung cancer after drug-induced pulmonary sarcoidosis with lung injury.
    Suzuki K; Kai Y; Kataoka R; Takeda M; Muro S
    Respirol Case Rep; 2024 Apr; 12(4):e01351. PubMed ID: 38617122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic Anaplastic Lymphoma Kinase Rearrangement-Positive Adenocarcinoma of Occult Primary Mimicking Ovarian Cancer.
    Chahin M; Krishnan N; Matthews-Hew T; Hew J; Pham D
    Cureus; 2020 Jul; 12(7):e9437. PubMed ID: 32864261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.